Literature DB >> 8102316

Nonamphetamine awakening agent modafinil induces feeding changes in the rat.

S Nicolaidis1, Z De Saint Hilaire.   

Abstract

In rats, modafinil, an alpha1 adrenergic receptor dependent, that has been shown to increase wakefulness without subsequent rebound effect, decreases feeding and reduces body weight. However, modafinil does not show a monotonic dose-related decrease in food intake. The dose-response curve for modafinil is U-shaped; feeding decreases after doses of 20 and 40 mg/kg, but no effects were seen after doses of 10 and 80 mg/kg. When feeding is resumed, no compensatory effect is seen, and body weight remains lower during the 24-h session. The drinking-to-feeding ratio remains unchanged, showing that modafinil has no effect on water intake. These results are discussed with reference to the possible mechanisms underlying the relation between sleep, feeding, and metabolism.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8102316     DOI: 10.1016/0361-9230(93)90060-o

Source DB:  PubMed          Journal:  Brain Res Bull        ISSN: 0361-9230            Impact factor:   4.077


  4 in total

1.  Efficacy and safety of modafinil (Provigil) for the treatment of fatigue in multiple sclerosis: a two centre phase 2 study.

Authors:  K W Rammohan; J H Rosenberg; D J Lynn; A M Blumenfeld; C P Pollak; H N Nagaraja
Journal:  J Neurol Neurosurg Psychiatry       Date:  2002-02       Impact factor: 10.154

2.  Modafinil decreases food intake in humans subjected to simulated shift work.

Authors:  Gydmer A Perez; Margaret Haney; Richard W Foltin; Carl L Hart
Journal:  Pharmacol Biochem Behav       Date:  2008-10       Impact factor: 3.533

3.  Depression-like deficits in rats improved by subchronic modafinil.

Authors:  Ralf Regenthal; Holger Koch; Christian Köhler; Rainer Preiss; Ute Krügel
Journal:  Psychopharmacology (Berl)       Date:  2009-03-03       Impact factor: 4.530

4.  Pitolisant, a wake-promoting agent devoid of psychostimulant properties: Preclinical comparison with amphetamine, modafinil, and solriamfetol.

Authors:  Stéphane Krief; Isabelle Berrebi-Bertrand; Isabelle Nagmar; Martin Giret; Simon Belliard; David Perrin; Marilyne Uguen; Philippe Robert; Jeanne-Marie Lecomte; Jean-Charles Schwartz; Olivier Finance; Xavier Ligneau
Journal:  Pharmacol Res Perspect       Date:  2021-10
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.